SOURCES SOUGHT
H -- Third Party Conformance Testing
- Notice Date
- 4/14/2017
- Notice Type
- Sources Sought
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of the Army, Army Contracting Command, ACC - APG (W911QY) Natick (SPS), BLDG 1 KANSAS ST, Natick, Massachusetts, 01760-5011, United States
- ZIP Code
- 01760-5011
- Solicitation Number
- W911QY-17-S-0009
- Archive Date
- 5/20/2017
- Point of Contact
- Leo J. Fratis, Phone: 2405861523
- E-Mail Address
-
leo.j.fratis.civ@mail.mil
(leo.j.fratis.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- This is a subsequent Request for Information (RFI) that will continue to seek out additional existing capabilities for a potential contract action. However, this RFI still remains for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited. No solicitation document exists or is guaranteed to be issued as a result of this RFI. If a response was submitted to the RFI posted on December 29, 2016, a second response is requested only if there are additional or supplementary information not originally included. The Defense Biological Product Assurance Office (previously known as the Critical Reagents Program) is seeking information on the capabilities and willingness of commercial entities specifically related to third party sterility verification as listed below. Background: The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) develops medical and physical countermeasures to protect the warfighter from chemicals and biological threats under the DoD Chemical and Biological Defense Program. In executing this mission, JPEO-CBD is responsible for developing and evaluating detection and diagnostic capability solutions, developing and evaluating the effectiveness of medical and physical protection capability solutions, developing and evaluating medical treatment capabilities, and verify the accuracy of test and evaluation equipment. Access to valid test materials, including potentially harmful biological materials known as BSAT (Biological Select Agents and Toxins) is required to perform these activities. JPEO-CBD established the CRP now DBPAO in Fiscal Year 1997 to ensure the standardization, quality, and availability of reagents that are crucial to the successful development, test and operation of DoD biological defense strategies. The DBPAO's mission is to employ best practices in providing the Department of Defense and its partners with a comprehensive collection of biological products that are thoroughly characterized, of the highest quality, adaptable, and traceable from source to application. DBPAO Requirement: The North American Industry Classification Systems (NAICS) for this notice are 325414 Biological Product (except Diagnostic) Manufacturing, 325413 Manufacturing in-vitro diagnostic, and 541380 Testing Laboratories. The Government is interested in the following information from qualified performers: Information on Third-Party Conformance Testing to include: a. Capability to work in Biosafety Level 1&2 containment (bacteria/virus) b. Capability to work in Biosafety Level 3 containment (bacteria/virus) c. Capability to work in Biosafety Level 4 containment (virus) d. Capability to perform third party verification of sterility testing on inactivated antigen and BSAT derivatives (bacteria/virus) (see the product list at: http://www.jpeocbd.osd.mil/packs/Default.aspx?pg=1220) If yes, to what extent? For example would you be willing to work with bacteria including spores (i.e., Bacillus anthracis) and viruses? e. Willingness to perform third party verification of sterility testing on inactivated antigen and BSAT derivatives (bacteria/virus) (see the product list at: http://www.jpeocbd.osd.mil/packs/Default.aspx?pg=1220) f. Understanding of Army Directive 2016-024 (DoD Biological Select Agent and Toxins Biosafety Program) (see AD 2016-024 at http://www.apd.army.mil/Search/ePubsSearch/ePubsSearchForm.aspx?x=ARMY+DIR) Respondents are invited to provide additional reading materials related to handling/testing of BSAT, commercial best practices, quality system, cost drivers in testing; quality controls and statistical process controls; and customer service capability. Administration: The Government will retain comments and information received in response to this RFI. Proprietary information should be identified as Company Proprietary. Do not use Government security classification markings. All written responses must be received by May 5, 2017. The Government Contracting Officer for this notice is Mr. Leo Fratis. Responses should be sent by e-mail to: leo.j.fratis.civ@mail.mil by regular mail to: Army Contracting Command - Aberdeen Proving Ground/Natick Division, Attn: Mr. Leo Fratis, 110 Thomas Johnson Drive, Suite 240, Frederick, Maryland 21702. Material that is advertisement only in nature is not desired.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/f552c8c8ceec8a6f886f6566882e5582)
- Record
- SN04472787-W 20170416/170414234102-f552c8c8ceec8a6f886f6566882e5582 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |